|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Sales and marketing | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest income | |||||
| Other income (expense): | |||||
| Interest expense | |||||
| Interest income | |||||
| Other income, net | |||||
| Total other income (expense), net | |||||
| Net loss | |||||
| Deemed dividend on warrant modification | |||||
| Net loss applicable to common stockholders | |||||
| Net Loss per share to common stockholders – Basic (in Dollars per share) | |||||
| Net Loss per share to common stockholders – Diluted (in Dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Weighted average common shares outstanding – Basic (in Shares) | |||||
| Weighted average common shares outstanding – Diluted (in Shares) | |||||
Loading...